Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals
- PMID: 19366976
- PMCID: PMC2699709
- DOI: 10.2337/dc09-0209
Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals
Abstract
Objective: To evaluate the association between 25-hydroxyvitamin D [25(OH)D] and metabolic syndrome in the Chinese population.
Research design and methods: Plasma 25(OH)D was measured in a cross-sectional sample of 1,443 men and 1,819 women aged 50-70 years from Beijing and Shanghai. Metabolic syndrome was defined according to the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian Americans. Fasting plasma glucose, insulin, lipid profile, A1C, and inflammatory markers were measured.
Results: The geometric mean of plasma 25(OH)D was 40.4 nmol/l, and percentages of vitamin D deficiency [25(OH)D <50 nmol/l] and insufficiency [50 <or= 25(OH)D <75 nmol/l] were 69.2 and 24.4%, respectively. Compared with the highest 25(OH)D quintile (>or=57.7 nmol/l), the odds ratio for metabolic syndrome in the lowest quintile (<or=28.7 nmol/l) was 1.52 (95% CI 1.17-1.98, P(trend) = 0.0002) after multiple adjustment. Significant inverse associations also existed between 25(OH)D and individual metabolic syndrome components plus A1C. Moreover, we observed significant inverse associations of 25(OH)D with fasting insulin and the insulin resistance index (homeostasis model assessment of insulin resistance [HOMA-IR]) in overweight and obese individuals (BMI >or=24 kg/m(2)) but not in their normal-weight counterparts (test for interaction: P = 0.0363 and 0.0187 for insulin and HOMA-IR, respectively).
Conclusions: Vitamin D deficiency is common in the middle-aged and elderly Chinese population, and a low 25(OH)D level is significantly associated with an increased risk of having metabolic syndrome and insulin resistance. Prospective studies and randomized clinical trials are warranted to determine the role of 25(OH)D in the development of metabolic syndrome and related metabolic diseases.
Comment in
-
Plasma 25-hydroxyvitamin d concentration and metabolic syndrome among middle-aged and elderly chinese individuals: response to Lu et al.Diabetes Care. 2010 Jan;33(1):e13; author reply e14. doi: 10.2337/dc09-1568. Diabetes Care. 2010. PMID: 20040663 No abstract available.
Similar articles
-
Higher serum 25(OH)D level is associated with decreased risk of impairment of glucose homeostasis: data from Southwest China.BMC Endocr Disord. 2018 May 9;18(1):25. doi: 10.1186/s12902-018-0252-4. BMC Endocr Disord. 2018. PMID: 29739382 Free PMC article.
-
Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001-2010.Nutr J. 2017 Feb 28;16(1):16. doi: 10.1186/s12937-017-0237-6. Nutr J. 2017. PMID: 28241878 Free PMC article.
-
Investigation of vitamin D status and its correlation with insulin resistance in a Chinese population.Public Health Nutr. 2017 Jun;20(9):1602-1608. doi: 10.1017/S1368980017000490. Epub 2017 Apr 5. Public Health Nutr. 2017. PMID: 28376939 Free PMC article.
-
Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women.Am J Clin Nutr. 2011 Jul;94(1):209-17. doi: 10.3945/ajcn.110.010272. Epub 2011 May 25. Am J Clin Nutr. 2011. PMID: 21613558 Free PMC article. Clinical Trial.
-
Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis.J Clin Endocrinol Metab. 2014 Mar;99(3):1053-63. doi: 10.1210/jc.2013-3577. Epub 2013 Jan 1. J Clin Endocrinol Metab. 2014. PMID: 24423309 Review.
Cited by
-
25-Hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008-2009 Korea National Health and Nutrition Examination Survey (KNHANES).Public Health Nutr. 2014 Jan;17(1):186-94. doi: 10.1017/S1368980012004855. Epub 2012 Nov 20. Public Health Nutr. 2014. PMID: 23168294 Free PMC article.
-
Higher serum 25(OH)D level is associated with decreased risk of impairment of glucose homeostasis: data from Southwest China.BMC Endocr Disord. 2018 May 9;18(1):25. doi: 10.1186/s12902-018-0252-4. BMC Endocr Disord. 2018. PMID: 29739382 Free PMC article.
-
Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review.World J Gastroenterol. 2018 Jan 28;24(4):445-460. doi: 10.3748/wjg.v24.i4.445. World J Gastroenterol. 2018. PMID: 29398866 Free PMC article. Review.
-
Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study.Cardiovasc Diabetol. 2011 Feb 10;10:17. doi: 10.1186/1475-2840-10-17. Cardiovasc Diabetol. 2011. PMID: 21306649 Free PMC article.
-
Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.Int J Clin Exp Med. 2015 Oct 15;8(10):17221-34. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26770315 Free PMC article.
References
-
- Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266– 281 - PubMed
-
- Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690– 693 - PubMed
-
- Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 2004; 79: 820– 825 - PubMed
-
- Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813– 2818 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical